{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:23:41Z","timestamp":1747196621677,"version":"3.40.5"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,13]]},"DOI":"10.7759\/cureus.84043","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:24:41Z","timestamp":1747167881000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Rupture and Death Following Administration of Recombinant Tissue-Type Plasminogen Activator (rt-PA)"],"prefix":"10.7759","author":[{"given":"Takashi","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhito","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Zenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.st.2019-0177","article-title":"Guidelines for intravenous thrombolysis (recombinant tissue-type plasminogen activator), the third edition, March 2019: a guideline from the Japan Stroke Society","volume":"59","author":"Toyoda K","year":"2019","unstructured":"Toyoda K, Koga M, Iguchi Y, et al.. Guidelines for intravenous thrombolysis (recombinant tissue-type plasminogen activator), the third edition, March 2019: a guideline from the Japan Stroke Society. Neurol Med Chir (Tokyo). 2019, 59:449-91. 10.2176\/nmc.st.2019-0177","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.02.039","article-title":"Myocardial infarction following intravenous thrombolysis for acute ischemic stroke: case report and literature review","volume":"26","author":"Mannino M","year":"2017","unstructured":"Mannino M, Asciutto S, Terruso V, Gammino M, Cellura MG, Monaco S. Myocardial infarction following intravenous thrombolysis for acute ischemic stroke: case report and literature review. J Stroke Cerebrovasc Dis. 2017, 26:e105-7. 10.1016\/j.jstrokecerebrovasdis.2017.02.039","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.04.014","article-title":"Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction","volume":"151","author":"Patel MR","year":"2006","unstructured":"Patel MR, Meine TJ, Lindblad L, et al.. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. Am Heart J. 2006, 151:316-22. 10.1016\/j.ahj.2005.04.014","journal-title":"Am Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-010-9384-8","article-title":"Cardiac rupture after intravenous t-PA administration in acute ischemic stroke","volume":"13","author":"Dhand A","year":"2010","unstructured":"Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, Tihan T. Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010, 13:261-2. 10.1007\/s12028-010-9384-8","journal-title":"Neurocrit Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821ccc72","article-title":"Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis","volume":"76","author":"De Silva DA","year":"2011","unstructured":"De Silva DA, Manzano JJ, Chang HM, Wong MC. Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis. Neurology. 2011, 76:1838-40. 10.1212\/WNL.0b013e31821ccc72","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65124","article-title":"Cardiocerebral infarction presenting in a neurosurgical emergency: a case report and literature review","volume":"16","author":"Kume H","year":"2024","unstructured":"Kume H, Maeda T, Tsukagoshi E, Ogura T, Ohmori S, Kurita H. Cardiocerebral infarction presenting in a neurosurgical emergency: a case report and literature review. Cureus. 2024, 16:e65124. 10.7759\/cureus.65124","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/366949-cardiac-rupture-and-death-following-administration-of-recombinant-tissue-type-plasminogen-activator-rt-pa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:24:42Z","timestamp":1747167882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/366949-cardiac-rupture-and-death-following-administration-of-recombinant-tissue-type-plasminogen-activator-rt-pa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.84043","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}